Sio Capital Management, LLC: 13F holdings, Q2 2026
Hedge fund · SEC EDGAR filings (CIK 1482416) · Explore on the interactive board
Sio Capital Management, LLC disclosed 57 US equity positions worth $583.5m in its Q2 2026 13F filing (holdings as of June 30, 2026, filed August 14, 2026). Its largest position is AVR at 9.4% of the reported book, followed by COR, MMS. The top ten holdings are 50.1% of the book, and the portfolio behaves like about 26 equal-weight positions. Versus the prior filing it opened 15 new positions, added to 10, reduced 21 and exited 25. Note: this manager's most recent filing is 3934 quarters behind the newest quarter on file, so these figures are history rather than current positioning.
What does Sio Capital Management, LLC own? Top holdings as of June 30, 2026
Change is measured in shares against the previous filing (Q1 2026), so price moves do not read as decisions. This quarter: 15 new, 10 added, 21 reduced, 25 exited.
| # | Stock | Sector | Weight | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|---|
| 1 | AVR ANTERIS TECHNOLOGIES GLOBAL | 9.4% | $54.6m | 5,545,984 | 3% | added | |
| 2 | COR CENCORA INC | Healthcare | 8.4% | $49.1m | 173,588 | 72% | added |
| 3 | MMS MAXIMUS INC | Industrials | 6.6% | $38.5m | 715,267 | -7% | reduced |
| 4 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 4.7% | $27.7m | 13,323,431 | – | new |
| 5 | GMED GLOBUS MED INC | Healthcare | 4.1% | $23.8m | 301,816 | – | new |
| 6 | GSK GSK PLC | Healthcare | 3.9% | $22.9m | 436,700 | 13% | added |
| 7 | TYRA TYRA BIOSCIENCES INC | Healthcare | 3.8% | $22.2m | 695,315 | 15% | added |
| 8 | WAY WAYSTAR HLDG CORP | Healthcare | 3.3% | $19.0m | 925,834 | -44% | reduced |
| 9 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.1% | $17.9m | 480,383 | – | new |
| 10 | ORKA ORUKA THERAPEUTICS INC | Healthcare | 2.9% | $16.9m | 177,118 | 34% | added |
| 11 | CI THE CIGNA GROUP | Healthcare | 2.7% | $15.9m | 57,750 | – | new |
| 12 | SNY SANOFI SA | Healthcare | 2.7% | $15.5m | 364,200 | 52% | added |
| 13 | ICLR ICON PUB LTD CO | Healthcare | 2.6% | $15.3m | 88,186 | -71% | reduced |
| 14 | VTRS VIATRIS INC | Healthcare | 2.6% | $15.2m | 954,299 | – | new |
| 15 | CROSS CTRY HEALTHCARE INC | 2.5% | $14.5m | 1,098,393 | 0% | held | |
| 16 | RAPP RAPPORT THERAPEUTICS INC | 2.2% | $12.8m | 307,657 | -16% | reduced | |
| 17 | ABT ABBOTT LABORATORIES | Healthcare | 2.0% | $11.7m | 128,656 | -31% | reduced |
| 18 | CELC CELCUITY INC | Healthcare | 2.0% | $11.5m | 110,022 | -43% | reduced |
| 19 | ZBH ZIMMER BIOMET HOLDINGS INC | Healthcare | 1.9% | $11.3m | 131,445 | 110% | added |
| 20 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.9% | $11.2m | 18,000 | – | new |
| 21 | BMY BRISTOL-MYERS SQUIBB CO | Healthcare | 1.9% | $11.1m | 193,500 | – | new |
| 22 | MDT MEDTRONIC PLC | Healthcare | 1.9% | $11.1m | 142,500 | – | new |
| 23 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 1.9% | $11.0m | 1,075,274 | -28% | reduced |
| 24 | SENS SENSEONICS HLDGS INC | 1.6% | $9.0m | 1,592,692 | 1276% | added | |
| 25 | EYPT EYEPOINT INC | Healthcare | 1.5% | $8.9m | 623,130 | -14% | reduced |
| 26 | HELP CYBIN INC | 1.5% | $8.6m | 1,300,000 | – | new | |
| 27 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.4% | $8.1m | 97,305 | -63% | reduced |
| 28 | TARA PROTARA THERAPEUTICS INC | 1.3% | $7.3m | 1,921,872 | -2% | reduced | |
| 29 | RLMD RELMADA THERAPEUTICS INC | Healthcare | 1.2% | $6.9m | 1,003,562 | 4% | added |
| 30 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.1% | $6.5m | 208,500 | – | new |
| 31 | AQST AQUESTIVE THERAPEUTICS INC | 1.1% | $6.2m | 1,486,175 | -23% | reduced | |
| 32 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 1.0% | $5.8m | 59,254 | -84% | reduced |
| 33 | SION SIONNA THERAPEUTICS INC | Healthcare | 1.0% | $5.6m | 127,808 | -57% | reduced |
| 34 | OCUL OCULAR THERAPEUTIX INC | Healthcare | 0.9% | $5.3m | 539,493 | -44% | reduced |
| 35 | ZBIO ZENAS BIOPHARMA INC | 0.9% | $5.3m | 208,557 | -37% | reduced | |
| 36 | DRUG BRIGHT MINDS BIOSCIENCES INC | Healthcare | 0.9% | $5.2m | 73,952 | -14% | reduced |
| 37 | OKUR ONKURE THERAPEUTICS INC | 0.8% | $4.9m | 1,078,965 | 0% | held | |
| 38 | SVRA SAVARA INC | Healthcare | 0.7% | $3.8m | 617,675 | 1% | added |
| 39 | PMVP PMV PHARMACEUTICALS INC | Healthcare | 0.6% | $3.5m | 2,634,137 | -14% | reduced |
| 40 | AVAH AVEANNA HEALTHCARE HLDGS INC | Healthcare | 0.5% | $3.2m | 369,036 | – | new |
| 41 | OVID OVID THERAPEUTICS INC | Healthcare | 0.5% | $2.7m | 1,005,334 | -20% | reduced |
| 42 | IMNM IMMUNOME INC | Healthcare | 0.5% | $2.6m | 124,168 | -25% | reduced |
| 43 | ANTX AN2 THERAPEUTICS INC | 0.4% | $2.6m | 529,933 | -19% | reduced | |
| 44 | SERINA THERAPEUTICS INC | 0.3% | $1.9m | 1,000,000 | 0% | held | |
| 45 | ALGS ALIGOS THERAPEUTICS INC | 0.3% | $1.9m | 327,237 | 0% | held | |
| 46 | IBIO IBIO INC | 0.3% | $1.6m | 904,268 | 0% | held | |
| 47 | XLO XILIO THERAPEUTICS INC | 0.3% | $1.5m | 152,464 | 0% | held | |
| 48 | AORT ARTIVION INC | Healthcare | 0.2% | $1.1m | 48,481 | – | new |
| 49 | BBOT BRIDGEBIO ONCOLOGY THERAPEUT | 0.2% | $995.4k | 130,628 | 0% | held | |
| 50 | TELA TELA BIO INC | 0.1% | $477.2k | 636,300 | 0% | held |
What did Sio Capital Management, LLC sell? Positions exited since the previous filing
| Stock | Prior weight | Prior value |
|---|---|---|
| CORT CORCEPT THERAPEUTICS INC | 12.7% | $27.2m |
| LIVN LIVANOVA PLC | 12.5% | $26.8m |
| EMBC EMBECTA CORP | 7.6% | $16.3m |
| ABVX ABIVAX SA | 7.0% | $15.1m |
| HAE HAEMONETICS CORP MASS | 5.8% | $12.4m |
| TFX TELEFLEX INCORPORATED | 5.3% | $11.3m |
| BMRN BIOMARIN PHARMACEUTICAL INC | 5.1% | $11.0m |
| GPCR STRUCTURE THERAPEUTICS INC | 4.7% | $10.1m |
| BHVN BIOHAVEN LTD | 4.6% | $9.8m |
| MNPR MONOPAR THERAPEUTICS INC | 4.4% | $9.5m |
| CRNXGBP CRINETICS PHARMACEUTICALS IN | 4.2% | $9.1m |
| EWTX EDGEWISE THERAPEUTICS INC | 3.9% | $8.5m |
| CMPS COMPASS PATHWAYS PLC | 3.9% | $8.3m |
| QDEL QUIDELORTHO CORP | 2.7% | $5.9m |
| REPL REPLIMUNE GROUP INC | 2.6% | $5.5m |
| OGN ORGANON & CO | 2.4% | $5.2m |
| IRON DISC MEDICINE INC | 1.9% | $4.2m |
| IART INTEGRA LIFESCIENCES HLDGS C | 1.7% | $3.6m |
| PROQR THERAPEUTICS N V | 1.5% | $3.2m |
| SI SHOULDER INNOVATIONS INC | 1.4% | $3.1m |
| KYMR KYMERA THERAPEUTICS INC | 1.3% | $2.7m |
| CNTX CONTEXT THERAPEUTICS INC | 1.1% | $2.4m |
| HYPR HYPERFINE INC | 0.5% | $1.1m |
| FHTX FOGHORN THERAPEUTICS INC | 0.3% | $587.4k |
| 430 TERNS PHARMACEUTICALS INC | 0.2% | $532.5k |
Sector mix
| Sector | Weight |
|---|---|
| Healthcare | 70.2% |
| Industrials | 6.6% |
Sectors cover positions whose ticker resolved to a sector; the remainder is unclassified, not cash.
Filing history
How concentrated is Sio Capital Management, LLC's portfolio?
Across every quarter Sio Capital Management, LLC has filed, its median largest position is 8.2% of the book and its median top-ten weight is 47.8%, which WhaleCreep classifies as concentrated (the gate is a median largest position of 5%). Of 31.0 completed holding spells, the median lasted 1.0 quarters; 57.0 positions are still open and their final length is unknown.